What is the APRN scope of practice and how does it vary by state?
+
APRN scope of practice for psychiatric nurse practitioners is set by each state's board of nursing and varies materially. The National Council of State Boards of Nursing (NCSBN) tracks scope across three categories: full-practice authority (the NP can evaluate, diagnose, prescribe, and manage independently), reduced-practice (collaborative or supervisory agreement with a physician required for some elements), and restricted-practice (physician supervision required for several elements including prescribing). The list of full-practice states grows over time. PMHNP-BC certification establishes the educational and clinical baseline; the state board determines what the PMHNP-BC may actually do in that state.
What is the DEA Ryan Haight Act and how does it affect telehealth controlled-substance prescribing?
+
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 generally requires an in-person medical evaluation by a DEA-registered practitioner before that practitioner can prescribe a controlled substance via the internet. The COVID-19 public health emergency expanded telehealth-prescribed controlled-substance flexibilities. The DEA published a Final Rule in 2023 and successive temporary extensions through 2024 and 2025 maintaining pathways under specified conditions, including for medication-assisted treatment for opioid use disorder. Psychiatric prescribers prescribing Schedule II stimulants for ADHD, Schedule IV benzodiazepines, or Schedule III testosterone via telehealth should consult the current DEA guidance because the rules continue to evolve.
What does the controlled-substance disclosure block at intake include?
+
A complete controlled-substance disclosure at psychiatric intake captures: current controlled-substance use (Schedule II through V), prescriber and pharmacy for each, dose and frequency, last-fill date, prior controlled-substance use including duration and reason for discontinuation, any history of substance use disorder, current substance use including alcohol and cannabis, and the patient's acknowledgment of the prescription monitoring program (PMP) query. The PMP consent is typically a separate signature block authorizing the prescriber to query the state PMP for the patient's controlled-substance history.
What is informed consent for psychotropic medication?
+
Informed consent for psychotropic medication typically discloses: the diagnosis being treated, the recommended medication and dose range, the expected benefits and time-to-effect, the common side effects (sleep changes, appetite changes, sexual side effects), the serious side effects (suicidality boxed warnings, neuroleptic malignant syndrome, metabolic effects, EPS, akathisia, depending on class), the recommended monitoring (metabolic panel, ECG for QT-prolonging agents, prolactin, lithium level, EPS scales), the alternatives including non-medication options, and the implications of discontinuation. The patient signs an acknowledgment that the prescriber discussed these elements. State-specific case law on adequacy of informed consent for psychotropic medication varies; review state-specific informed-consent standards.
How are CMS E&M billing codes used for psychiatric NP visits?
+
Psychiatric NPs typically bill psychiatric services using CPT 90791 (psychiatric diagnostic evaluation, no medical services) or 90792 (with medical services), and follow-up medication-management visits using E&M codes 99202 through 99205 (new patient) or 99212 through 99215 (established patient), often with add-on codes for psychotherapy when delivered alongside medication management (90833, 90836, 90838). CMS Medicare Fee Schedule adjustments and the 2021 E&M coding revisions changed time-based and medical-decision-making documentation requirements. Many psychiatric NPs use 99214 or 99215 with a psychotherapy add-on for combined visits.
How is CPT 90791 used at intake?
+
CPT 90791 is the psychiatric diagnostic evaluation code used at the first visit. It captures the comprehensive intake assessment including history of present illness, psychiatric history, medical history, family history, social history, mental status examination, and the diagnostic formulation. CPT 90791 does not include medical services; CPT 90792 includes medical services (medication initiation or adjustment) at the same visit. Psychiatric NPs and psychiatrists most often bill 90792 at intake when starting a medication or adjusting one; 90791 is more common for psychotherapy-focused intakes that defer prescribing to a later visit.
What about drug-drug interaction documentation?
+
Drug-drug interaction (DDI) documentation at psychiatric intake captures all prescription medications, over-the-counter medications, supplements, and substances. The prescriber checks against psychotropic-relevant interactions: CYP2D6 and CYP3A4 inhibitors and inducers, MAOI washout periods, SSRI plus serotonergic agents, lithium plus thiazides or NSAIDs, lamotrigine plus valproate dose adjustments, and others. The intake form captures the medication list; the prescriber documents the DDI review in the chart. Many practices use a clinical decision support tool tied to the EHR for the DDI check; the intake form provides the inputs.
What is the BAA requirement and when is it needed?
+
A Business Associate Agreement (BAA) is required under HIPAA between a covered entity (the prescriber or practice) and a business associate (a vendor handling PHI on behalf of the covered entity) when the vendor has access to PHI in the course of the service. For psychiatric medication management practices, the EHR vendor, the e-prescribing vendor, and the intake-form vendor that captures PHI all typically require a BAA. SimplePractice publicly markets BAA availability. Formfy implements encryption + audit trails but does not claim HIPAA certification; practices with covered-entity status should evaluate their compliance posture accordingly.
How do practices handle the PMP query at intake?
+
Most state prescription monitoring programs (PMPs) require the prescriber to query before prescribing controlled substances, with the specific threshold (every prescription, every X days, first-time prescription only) varying by state. The intake form typically includes a PMP consent block where the patient acknowledges that the prescriber will query the state PMP. The query itself happens through the state PMP portal or an EHR-integrated PMP module, not through the intake form. The intake captures the patient acknowledgment and consent for the query.
How does cross-state telehealth licensure work for psychiatric NPs?
+
A psychiatric NP delivering medication management via telehealth must generally be licensed in the state where the patient is physically located at the time of the visit. The Nurse Licensure Compact (NLC) is the multistate licensure compact for RNs and LPNs but does NOT cover APRN practice. The APRN Compact has been enacted by some states but remains in development. For now, most psychiatric NPs practicing across state lines hold individual state licenses in each state where patients reside. State-specific telehealth-consent rules layer on top of the licensure question.
What about state-specific minor consent for psychiatric medication?
+
State-specific minor consent laws govern when a minor can consent to mental-health treatment (including psychiatric medication) without parental involvement. Some states allow minors to consent to outpatient mental-health treatment beginning at certain ages or for certain conditions; some require parental consent for any psychiatric medication. Psychiatric prescribers seeing adolescents should know the state-specific rule before relying on any default. The AACAP Practice Parameters discuss consent and assent for child and adolescent psychiatry; state law controls the legal-consent question.
Are e-signatures valid on psychiatric medication consent forms?
+
Yes. The federal Electronic Signatures in Global and National Commerce Act (ESIGN Act) and the Uniform Electronic Transactions Act (UETA) adopted by 49 states give electronic signatures the same legal effect as wet-ink signatures for healthcare consent forms. Tools that capture a tamper-evident audit trail with timestamps, IP addresses, and consent-to-electronic-records language produce the strongest record. Formfy, SimplePractice, TherapyNotes, Jane App, and similar tools all meet this bar.
How are psychiatric medication intake forms different from psychotherapy intake?
+
Psychiatric medication intake adds: full medication reconciliation across all current and recent medications (psychotropic and otherwise), allergy history with reaction details, current and prior controlled-substance exposure, primary pharmacy and any specialty pharmacy with ROI, prescription monitoring program consent, prior psychotropic medication trials with response and reason for discontinuation, family psychiatric history with treatment response if known, metabolic baseline acknowledgment for relevant agents, ECG history for QT-prolonging agents, and informed consent for the specific medication class. Psychotherapy intake captures clinical history and informed consent for therapy without the medication-reconciliation depth.
How fast can a psychiatric NP send a fully compliant intake using AI tools?
+
With an AI form builder like Formfy, a psychiatric NP can describe the intake in plain English (PMHNP-BC scope acknowledgment, medication reconciliation, allergy history, controlled-substance disclosure, primary-pharmacy ROI, PMP consent, informed consent for psychotropic medication, telemedicine consent if applicable, collaborative practice agreement acknowledgment if state-required) and have a delivery-ready intake form in under 30 seconds. The historical bottleneck was assembling a Word document with 8 to 12 separate consent blocks, converting to PDF, uploading to an e-signature tool, and managing the field placement. AI generation collapses that into one prompt.
Why does the listicle put Formfy first?
+
Two reasons. First, Formfy is the only tool on the list that bundles AI form generation, e-signature with audit trail, multi-block consent (medication, controlled substance, pharmacy, PMP, telemedicine, collaborative practice acknowledgment), and optional copay collection in a submission-priced subscription that does not penalize a practice for adding new patients. Second, the founder-to-founder honesty point: every tool on the list does part of what Formfy does. AANP and ANCC give you the scope-aligned content; Psych Congress gives you contemporary clinical content; AAPP gives you the pharmacist-collaboration perspective; CCHP gives you the telehealth statute summaries. Formfy gives you the workflow.
